{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:57:15Z","timestamp":1775573835457,"version":"3.50.1"},"reference-count":8,"publisher":"Aboutscience Srl","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Grhta"],"abstract":"<jats:p>Introduction: Italy retains a unique wealth of information on drug usage, embodied in the OsMed Report, published since 2001 and based on data collected by the National Observatory on the Use of Medicines. The Reportanalyzes data on drug dispensing, pharmaceutical expenditure, and prescribing appropriateness; it monitors regional and temporal variations in drug use and identifies public health issues, promoting a more appropriate useof medicines.Methods: As part of the III Edition of the Forum on Regional Pharmaceutical Policies, titled \u201cEnsuring equitableand consistent access to pharmaceutical care while safeguarding the sustainability of the National HealthService\u201d, a dedicated Working Group examined how Regions can apply the OsMed Report to share strategies toimprove therapeutic appropriateness.Results: The discussion emphasized the need for more efficient management of health data and a greater interoperability between information systems to enhance institutional responsiveness. Additionally, the Groupexplored the development of indicators linking pharmaceutical consumption to clinical outcomes, which couldsupport regional planning through predictive and up to date tools.Conclusion: The Working Group highlighted the strengths and weaknesses of the OsMed Report, proposing solutions to make it more accessible and useful at the regional level, to promote therapeutic adherence and toimprove the transparency of drug access timelines.<\/jats:p>","DOI":"10.33393\/grhta.2026.3684","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:07:13Z","timestamp":1775570833000},"page":"74-78","source":"Crossref","is-referenced-by-count":0,"title":["How Regions can leverage the OsMed Report to disseminate initiatives aimed at improving appropriateness"],"prefix":"10.33393","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7181-6356","authenticated-orcid":false,"given":"Silvia","family":"Sansone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-0577","authenticated-orcid":false,"given":"Maria Cristina","family":"Carena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7974-6299","authenticated-orcid":false,"given":"Giorgia","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Da Cas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6238-0158","authenticated-orcid":false,"given":"Giuseppe","family":"Traversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18642","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"19185","unstructured":"Agenzia Italiana del Farmaco (AIFA). Osmed. L\u2019uso dei farmaci in Italia. Rapporto Nazionale Anno 2024. 2025. Online https:\/\/www.aifa.gov.it\/-\/l-uso-dei-farmaci-in-italia-rapporto-osmed-2024 (Accessed November 2025)"},{"key":"19186","unstructured":"Agenzia Italiana del Farmaco (AIFA). OsMed interattivo. Online https:\/\/www.aifa.gov.it\/osmed-interattivo (Accessed November 2025)"},{"key":"19187","unstructured":"Agenzia Italiana del Farmaco (AIFA). Report regionali sul consumo dei farmaci in Italia \u2013 anno 2023. Online https:\/\/www.aifa.gov.it\/-\/report-regionali-consumo-farmaci-italia-anno-2023 (Accessed November 2025)"},{"key":"19188","unstructured":"Agenzia Italiana del Farmaco (AIFA). Spesa e consumo relativi al flusso della farmaceutica convenzionata e degli acquisti diretti. Online https:\/\/www.aifa.gov.it\/web\/guest\/spesa-e-consumo-relativi-al-flusso-della-farmaceutica-convenzionata-e-degli-acquisti-diretti (Accessed November 2025)"},{"key":"19189","unstructured":"Agenzia Italiana del Farmaco (AIFA). Monitoraggio mensile della spesa e dei consumi dei farmaci biosimilari. Online https:\/\/www.aifa.gov.it\/monitoraggio-consumi-e-spesa-biosimilari (Accessed November 2025)"},{"key":"19190","unstructured":"Agenzia Italiana del Farmaco (AIFA). Monitoraggio dei farmaci non biologici a brevetto scaduto. Online https:\/\/www.aifa.gov.it\/monitoraggio-farmaci-non-biologici-a-brevetto-scaduto (Accessed November 2025)"},{"key":"19191","unstructured":"Altems Advisory. Analisi della Governance dell\u2019Accesso ai Farmaci nelle Regioni Italiane: Ruolo, Struttura e Prospettive dei Prontuari Terapeutici Regionali. 2025. Online https:\/\/www.altemsadvisory.it\/wp-content\/uploads\/2026\/01\/Altems-Advisory-Desk-Ana"},{"key":"19192","unstructured":"Dephaforum. Forum Politiche Farmaceutiche Regionali - Seconda Edizione. Online https:\/\/www.dephaforum.it\/forum-politiche-farmaceutiche-regionali\/forum-politiche-farmaceutiche-regionali-seconda-edizione (Accessed November 2025)"}],"container-title":["Global and Regional Health Technology Assessment"],"original-title":[],"link":[{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/3684\/4258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/3684\/4259","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/download\/3684\/4258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:16:11Z","timestamp":1775571371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/grhta\/article\/view\/3684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.33393\/grhta.2026.3684","relation":{},"ISSN":["2283-5733","2284-2403"],"issn-type":[{"value":"2283-5733","type":"electronic"},{"value":"2284-2403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}